Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02058693 · ClinicalTrials.gov registry record · Phase 4
Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy
A Phase 4 study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT02058693 is a Phase 4 study that has completed, run by Rush University Medical Center. The registered enrollment target is 41 participants.
The verdict
NCT02058693, a Phase 4 study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
In this Phase 4 trial we will study the safety, tolerability and efficacy of mixed salts amphetamine (MSA), trade name Adderall, augmentation of antidepressant therapy for Major Depressive Disorder (MDD) in depressed outpatient adults who are taking an antidepressant but have not had complete resolution of their symptoms.
Interventions
- DRUG mixed salts amphetamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02058693
The ClinicalTrials.gov registry entry for NCT02058693 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mixed salts amphetamine is the first listed.
NCT02058693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02058693 about?
NCT02058693 is a clinical study titled "Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy". In this Phase 4 trial we will study the safety, tolerability and efficacy of mixed salts amphetamine (MSA), trade name Adderall, augmentation of antidepressant therapy for Major Depressive Disorder (MDD) in depressed outpatient adults who are taking an antidepressant but have not had complete resolu...
What is the current status of trial NCT02058693?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2010-12. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02058693?
The interventions under investigation include: mixed salts amphetamine (DRUG).
Who is sponsoring clinical trial NCT02058693?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.